Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01988987 · ClinicalTrials.gov registry record
Evaluating for Type-2 Diabetes in the Very Early Postpartum Period
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 123
- Enrollment target
NCT01988987: Completed study, sponsored by NYU Langone Health.
NCT01988987 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 123 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01988987 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 123 participants
- Enrollment target
Study Summary
Pregnancy-associated diabetes, known as gestational diabetes mellitus (GDM), is associated with an increased lifetime risk of developing diabetes mellitus (DM) or pre-diabetes. Up to 30% of women with GDM will continue have abnormal blood glucose tests 6 or more weeks after delivery. Early diagnosis and treatment of continued impaired glucose metabolism or DM is essential because serious health problems can result. Current guidelines recommend a 75-gram, 2-hour glucose tolerance test (GTT) 6 or more weeks after delivery for women diagnosed with GDM in order to identify those with continued DM or impaired glucose metabolism. However, approximately half of these women do not get glucose testing after delivery. The ability to test women while they are still hospitalized after having a baby could greatly increase diagnosis, care and treatment of women with abnormal glucose metabolism. Our objective is to determine if a 75-gram, 2-hour GTT administered to women with GDM two to four days after delivery can identify those who will have an abnormal GTT at 6-12 weeks after delivery.
Primary Outcome
The GTT result obtained 2-4 days postpartum will be compared to the GTT result obtained 6-12 weeks postpartum using the McNemar test for paired proportions.
Interventions
- OTHER Inpatient Postpartum GTT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 123 participants |
| Start Date | 2013-02-22 |
| Est. Completion | 2018-11-30 |
What the finished NCT01988987 record still lists
NCT01988987 is an observational study that tracks outcomes without assigning an intervention. The registered 123 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Inpatient Postpartum GTT is the first listed.
NCT01988987 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01988987 about?
NCT01988987 is a clinical study titled "Evaluating for Type-2 Diabetes in the Very Early Postpartum Period". Pregnancy-associated diabetes, known as gestational diabetes mellitus (GDM), is associated with an increased lifetime risk of developing diabetes mellitus (DM) or pre-diabetes. Up to 30% of women with GDM will continue have abnormal blood glucose tests 6 or more weeks after delivery. Early diagnosis...
What is the current status of trial NCT01988987?
This trial is currently completed. The enrollment target is 123 participants. The study started on 2013-02-22. Estimated completion is 2018-11-30.
What interventions are being tested in trial NCT01988987?
The interventions under investigation include: Inpatient Postpartum GTT (OTHER).
Who is sponsoring clinical trial NCT01988987?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05285891 · 123 participants · Phase 4
Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis
- NCT05334368 · 123 participants · Phase 3
Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial
- NCT06088355 · 123 participants · NA
Moderate Versus High Volume Light-Moderate Intensity Exercise for People With Moderate Parkinson's Disease
- NCT06111131 · 123 participants · NA
Ancora-SB Overtube Complete Positioning and Optical Visualization During Endoscopic Procedures
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI